JPRN-UMIN000028924已完成未知
The effects on skin elasticity and hormone levels of blood by long-term ingestion of test food in human: a double-blind, randomized placebo-controlled, parallel comparison study - The effects on skin elasticity and hormone levels of blood by long-term ingestion of test food in human
DRC Corporation, Ltd. Product Testing Department No.9 Tabuchi Bldg. 3F, 2-10-31, Higashi-Temma, Kita-ku, Osaka Tel: 81-(0)6-6882-11300 个研究点目标入组 20 人开始时间: 2019年3月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30years-old 至 50years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Subjects who continuously take a functional food or a supplement. 2) Subjects who continuously take a functional food or quasi-medicine which has same or similar effect with active ingredient of test food. 3) Subjects who frequently intake food which is rich in same active ingredient of test food, or who intake these kind of food during 3 days before and after trial initiation and the last 3 days from the end of trial. 4) Subjects who work on the night shift or the day and night shift. 5) Subjects who are receiving the medical treatment or the prophylactic treatment, or who are diagnosed the need of medical treatment. 6) Subjects who have skin disease or abnormality in skin condition such as atopic dermatitis. 7) Subjects who show the apparent change of skin condition which is not related to the intake of test food at the end of trial compared with the initiation. 8) Subjects who have a past history for the severe disease or abnormality in glucose metabolism, lipid metabolism, liver function, kidney function, cardiovascular system including heart function, respiratory tract, endocrine system and nerve system, or for psychiatric disorder. 9) Subjects who suffer from anemia, or felt sick due to blood collection. 10) Subjects who have a past history of alcoholism or drug addiction. 11) Subjects who have a risk for food allergy. 12) Subjects who show apparent abnormality in blood test, or who are positive for HBs antigen or HCV antibody in trial duration including the screening period. 13) Subjects who are pregnant or during lactation when the informed consent is provided, or who hope to become pregnant during the trial. 14) Subjects who were involved in another trial within 4 weeks prior to this trial, who will participate in another trial. 15) Subjects who are judged to be inappropriate for this trial by the doctor who is responsible for this trial.
研究者
相似试验
已完成
不适用
Influence on skin barrier function and elasticity by using serumHealthy adult femaleJPRN-UMIN000037755Japan Clinical Trial Association19
尚未招募
Unknown
Alterations in skin hydration, moisture and genomic in patients with dry skin conditions following daily oral palm tocotrienol and squalene (STGAIATM) supplementatioDry skinxerosisSkin - Dermatological conditionsACTRN12624001057572Monash University Malaysia36
已完成
不适用
se of insulin sensitisers to revert metabolic syndromeISRCTN58810841Hospital Sant Joan de Deu (Spain)52
已完成
不适用
Body compositional and endocrine-metabolic changes by long-term lifestyle intervention with health education, diet (Almased®), physical activity or a combination of diet and physical activity in obese personsDietoverweightE66.0Obesity due to excess caloriesDRKS00000010niversitätsklinikum Freiburg114
已完成
Unknown
Effect of the test food on skin viscoelasticityHealthy subjectJPRN-UMIN000051832DRC Co., Ltd.36